Yidu Tech Inc. (2158.HK) stock price, financials & research

Regular session · HKT · Market data may be delayed.

Company profile

Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.

Industry: Medical - Healthcare Information Services
Sector: Healthcare
Headquarters: CN
CEO: Jiming Xu
Listed since: Jan 15, 2021
Employees: 754

Market position

Day range

Current HK$3.815

HK$3.74HK$3.905

52-week range

Current HK$3.815

HK$3.745HK$7.22

Open: HK$3.885
Previous close: HK$3.875
Volume: 22.41M; 3.2× average
Average volume: 7M; Average daily volume
Market cap: 3.89B HKD
Beta: 1.3; Market reference 1
50-day average: HK$4.7341; -19.41% below average
200-day average: HK$5.3811; -29.10% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 3.93B CNY
P/E (TTM): 49.78×
P/B (TTM): 0.97×
P/S (TTM): 4.12×
EV / EBITDA: -71.59×
Earnings yield: 1.55%
Free cash flow yield: -1.14%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 36.44%
Operating margin: 1.50%
Net margin: 8.74%
Return on equity: 1.93%
Return on assets: 1.63%
Return on invested capital: -2.25%

Financial health

Debt / equity: 0.02×
Current ratio: 4.81×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

790.51M CNY+10.56%

Operating income

−90.28M CNY+32.70%

Net income

70.15M CNY+187.94M CNY

Metric (CNY)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	790.51M CNY	714.98M CNY	807.08M CNY	804.7M CNY	1.24B CNY
Cost of goods sold	502.5M CNY	475.8M CNY	467.63M CNY	530.2M CNY	840.31M CNY
Gross profit	288.01M CNY	239.18M CNY	339.45M CNY	274.5M CNY	396.9M CNY
Research and development	159.1M CNY	186.48M CNY	232.93M CNY	342.52M CNY	368.66M CNY
Selling, general, and administrative	190.95M CNY	285.55M CNY	380.21M CNY	503.63M CNY	750.97M CNY
Operating expenses	378.29M CNY	373.33M CNY	559.36M CNY	979.59M CNY	1.17B CNY
Interest income	1.7M CNY	158.83M CNY	143.29M CNY	78.76M CNY	5.51M CNY
Interest expense	1.87M CNY	2.01M CNY	3.31M CNY	2.61M CNY	4.21M CNY
Depreciation and amortization	35.42M CNY	43.3M CNY	47.11M CNY	46.35M CNY	46.94M CNY
Operating income	−90.28M CNY	−134.15M CNY	−219.92M CNY	−617.6M CNY	−759.83M CNY
Net income	70.15M CNY	−117.79M CNY	−194.94M CNY	−627.97M CNY	−762.32M CNY